奥佳华(002614) - 2021 Q4 - 年度财报

Financial Performance - The company's operating revenue for 2021 was approximately CNY 7.93 billion, representing a year-on-year increase of 12.25% compared to CNY 7.05 billion in 2020[19]. - The net profit attributable to shareholders of the listed company for 2021 was approximately CNY 458.36 million, an increase of 4.34% from CNY 439.28 million in 2020[19]. - The company reported a significant decrease of 65.66% in the net profit attributable to shareholders in the adjusted figures, compared to CNY 413.62 million in 2020[19]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, decreased by 65.66% compared to the previous year, primarily due to significant increases in raw material prices, fluctuations in the RMB to USD exchange rate, rising shipping costs, and asset impairment losses[20]. - The global health massage business achieved revenue of 5.497 billion yuan, representing a year-on-year growth of 23.81%[20]. - Revenue from the company's own health massage brand reached 2.8 billion yuan, with a year-on-year increase of 33.10%[20]. - The total assets at the end of 2021 were 9.265 billion yuan, an increase of 3.50% compared to the end of 2020[20]. - The net assets attributable to shareholders increased by 8.00% to 4.829 billion yuan at the end of 2021[20]. - The basic earnings per share for the year were 0.74 yuan, a decrease of 3.90% compared to the previous year[20]. - The diluted earnings per share remained stable at 0.68 yuan, unchanged from the previous year[20]. - The weighted average return on equity was 9.89%, down from 12.11% in the previous year[20]. - The company reported a net cash flow from operating activities of -17.52 million yuan, a significant decline of 102.44% compared to the previous year[20]. Dividend Distribution - The company plans to distribute a cash dividend of CNY 3 per 10 shares (including tax) to all shareholders, with no bonus shares issued for the year[4]. - The total distributable profit for the year is RMB 2,276,641,927.01, with cash dividends accounting for 100% of the profit distribution[135]. Business Operations - The company has not changed its major business operations since its listing, focusing on the research and sales of health-related products[18]. - The company plans to focus on core business areas, enhance technological innovation, and strengthen its own brand development while divesting non-core businesses[30]. - The company is focusing on a "product + service" model, integrating AI technology into its massage products to enhance user experience[47]. - The company is expanding its international presence with brands like "OGAWA" in international markets, "FUJI" in Taiwan, and "cozzia" in North America[94]. - The company is shifting some resources towards the development of small massage appliances for the domestic market[95]. Research and Development - The company invested 289 million CNY in R&D during the reporting period, focusing on integrating traditional Chinese medicine with modern digital technology[36]. - The company has accumulated 1,160 patents and was recognized among the top 500 private enterprises for R&D investment and invention patents in 2021[42]. - The company has a total of 931 R&D personnel, an increase of 10.70% from 841 in the previous year[61]. Market Position and Sales - The health massage segment's revenue grew by 23.81% year-on-year, accounting for 71.26% of the main business revenue[50]. - The sales volume of massage chairs reached 470,100 units, an increase of 17.50% compared to the previous year[55]. - The company has an annual production capacity of 700,000 smart massage chairs and over 17 million small massage appliances[44]. - The gross profit margin for the main business was 30.26%, down 4.33% year-on-year, primarily due to rising raw material costs[52]. - The main brand "OGAWA" continues to lead in the domestic market, with a new range of smart massage products launched to meet diverse consumer needs[45]. - Domestic sales accounted for 22.10% of total revenue, while international sales made up 77.90%, with a year-on-year growth of 11.74%[50]. Corporate Governance - The company has established a strong governance structure with independent directors and a diverse board composition[112]. - The management team includes professionals with extensive experience in their respective fields, ensuring effective leadership and operational oversight[113]. - The company is committed to maintaining transparency and accountability in its financial reporting and corporate governance practices[110]. - The company has a structured approach to corporate governance, ensuring compliance and accountability among its board members[116]. Risk Management - The company faces risks from macroeconomic fluctuations that could impact the demand for its massage products[97]. - The ongoing COVID-19 pandemic poses risks to daily activities and global supply chains, affecting the company's operations[98]. - Rising raw material and shipping costs could adversely affect the company's business if these trends continue[99]. - The company has a risk control system in place for financial derivatives trading, ensuring compliance with regulatory requirements and effective risk management[78]. Social Responsibility - The company actively engages in social responsibility, supporting pandemic prevention efforts and promoting community welfare[146]. - The company donated a total of RMB 3.6598 million in pandemic prevention materials to various organizations, including RMB 1 million specifically for a cardiac surgery fund[152]. - The company has actively participated in poverty alleviation projects, donating over RMB 2.3 million and approximately RMB 190,000 worth of books to impoverished areas[153]. Internal Controls - The company has established a scientific internal control system to effectively prevent operational risks[138]. - There were significant internal control deficiencies identified, including non-operating fund occupation amounting to RMB 61.5 million, which has been rectified[139]. - The company has implemented measures to improve internal controls and enhance the quality of information disclosure following the warning received[165]. Shareholder Information - The company reported a total of 243,483,791 shares held by directors and senior management, with no changes in shareholding during the reporting period[110]. - Major shareholders include Zou Jianhan with 20.23% (127,620,000 shares) and Li Wuling with 17.82% (112,420,091 shares) as of the end of the reporting period[187]. - The company’s share capital increased to 630,693,012 shares, with a total increase of 12,017,212 shares during the reporting period[178].